588 related articles for article (PubMed ID: 31305284)
1. ALPPS Versus Portal Vein Embolization for Hepatitis-related Hepatocellular Carcinoma: A Changing Paradigm in Modulation of Future Liver Remnant Before Major Hepatectomy.
Chan A; Zhang WY; Chok K; Dai J; Ji R; Kwan C; Man N; Poon R; Lo CM
Ann Surg; 2021 May; 273(5):957-965. PubMed ID: 31305284
[TBL] [Abstract][Full Text] [Related]
2. Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients.
Charalel RA; Sung J; Askin G; Jo J; Mitry M; Chung C; Tmanova L; Madoff DC
Curr Oncol Rep; 2021 Oct; 23(11):135. PubMed ID: 34716800
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous portal and hepatic vein embolization is better than portal embolization or ALPPS for hypertrophy of future liver remnant before major hepatectomy: A systematic review and network meta-analysis.
Gavriilidis P; Marangoni G; Ahmad J; Azoulay D
Hepatobiliary Pancreat Dis Int; 2023 Jun; 22(3):221-227. PubMed ID: 36100542
[TBL] [Abstract][Full Text] [Related]
4. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery.
Zhang GQ; Zhang ZW; Lau WY; Chen XP
Int J Surg; 2014; 12(5):437-41. PubMed ID: 24704086
[TBL] [Abstract][Full Text] [Related]
5. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization.
Matsuo K; Murakami T; Kawaguchi D; Hiroshima Y; Koda K; Yamazaki K; Ishida Y; Tanaka K
Surgery; 2016 May; 159(5):1289-98. PubMed ID: 26775576
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach.
Shindoh J; Vauthey JN; Zimmitti G; Curley SA; Huang SY; Mahvash A; Gupta S; Wallace MJ; Aloia TA
J Am Coll Surg; 2013 Jul; 217(1):126-33; discussion 133-4. PubMed ID: 23632095
[TBL] [Abstract][Full Text] [Related]
7. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.
Tschuor Ch; Croome KP; Sergeant G; Cano V; Schadde E; Ardiles V; Slankamenac K; Clariá RS; de Santibaňes E; Hernandez-Alejandro R; Clavien PA
Eur J Surg Oncol; 2013 Nov; 39(11):1230-5. PubMed ID: 23994139
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of Percutaneous Intrahepatic Split by Microwave Ablation (PISA) After Portal Vein Embolization for Hypertrophy of Future Liver Remnant: The Radiological Stage-1 ALPPS.
Lunardi A; Cervelli R; Volterrani D; Vitali S; Lombardo C; Lorenzoni G; Crocetti L; Bargellini I; Campani D; Pollina LE; Cioni R; Caramella D; Boggi U
Cardiovasc Intervent Radiol; 2018 May; 41(5):789-798. PubMed ID: 29359240
[TBL] [Abstract][Full Text] [Related]
9. Greater hypertrophy can be achieved with associating liver partition with portal vein ligation for staged hepatectomy compared to conventional staged hepatectomy, but with a higher price to pay?
Chia DKA; Yeo Z; Loh SEK; Iyer SG; Bonney GK; Madhavan K; Kow AWC
Am J Surg; 2018 Jan; 215(1):131-137. PubMed ID: 28859921
[TBL] [Abstract][Full Text] [Related]
10. Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatocellular carcinoma: a randomized comparative study.
Li PP; Huang G; Jia NY; Pan ZY; Liu H; Yang Y; He CJ; Lau WY; Yang YF; Zhou WP
Hepatobiliary Surg Nutr; 2022 Feb; 11(1):38-51. PubMed ID: 35284529
[TBL] [Abstract][Full Text] [Related]
11. Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS.
Chan ACY; Chok K; Dai JWC; Lo CM
Surgery; 2017 Feb; 161(2):357-364. PubMed ID: 27596751
[TBL] [Abstract][Full Text] [Related]
12. Immaturity of Bile Canalicular-Ductule Networks in the Future Liver Remnant While Associating Liver Partition and Portal Vein Occlusion for Staged Hepatectomy (ALPPS).
Matsuo K; Hiroshima Y; Yamazaki K; Kasahara K; Kikuchi Y; Kawaguchi D; Murakami T; Ishida Y; Tanaka K
Ann Surg Oncol; 2017 Sep; 24(9):2456-2464. PubMed ID: 28612126
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of different options for liver regeneration of future liver remnant in patients with liver malignancies: a systematic review and network meta-analysis.
Yi F; Zhang W; Feng L
World J Surg Oncol; 2022 Dec; 20(1):399. PubMed ID: 36527081
[TBL] [Abstract][Full Text] [Related]
14. ALPPS Procedure in Insufficient Hypertrophy After Portal Vein Embolization (PVE).
Ulmer TF; de Jong C; Andert A; Bruners P; Heidenhain CM; Schoening W; Schmeding M; Neumann UP
World J Surg; 2017 Jan; 41(1):250-257. PubMed ID: 27464917
[TBL] [Abstract][Full Text] [Related]
15. Is ALPPS still appropriate for large or locally advanced hepatocellular carcinoma in an era of targeted agents and immunotherapy?
Lu YX; Zhao JP; Zhang WG
Updates Surg; 2024 Jun; 76(3):899-910. PubMed ID: 38526694
[TBL] [Abstract][Full Text] [Related]
16. Sequential Portal Vein Embolization and Percutaneous Radiofrequency Ablation for Future Liver Remnant Growth: A Minimally Invasive Alternative to ALPPS Stage-1 in Treatment of Hepatocellular Carcinoma.
Wang Q; Ji Y; Brismar TB; Chen S; Li C; Jiang J; Mu W; Zhang L; Sparrelid E; Ma K
Front Surg; 2021; 8():741352. PubMed ID: 34660682
[No Abstract] [Full Text] [Related]
17. Technical modifications and outcomes after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) for primary liver malignancies: A systematic review.
Baili E; Tsilimigras DI; Moris D; Sahara K; Pawlik TM
Surg Oncol; 2020 Jun; 33():70-80. PubMed ID: 32561102
[TBL] [Abstract][Full Text] [Related]
18. [Meta-analysis of the outcomes of associating liver partition and portal vein ligation for staged hepatectomy versus portal vein embolization for the treatment of liver cancer with insufficient future liver remnant].
Cao YL; Wang GJ; Li W
Zhonghua Wai Ke Za Zhi; 2019 Jul; 57(7):540-548. PubMed ID: 31269618
[No Abstract] [Full Text] [Related]
19. Rescue associating liver partition and portal vein ligation for staged hepatectomy after portal embolization: Our experience and literature review.
Maulat C; Philis A; Charriere B; Mokrane FZ; Guimbaud R; Otal P; Suc B; Muscari F
World J Clin Oncol; 2017 Aug; 8(4):351-359. PubMed ID: 28848702
[TBL] [Abstract][Full Text] [Related]
20. Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis.
Croome KP; Hernandez-Alejandro R; Parker M; Heimbach J; Rosen C; Nagorney DM
HPB (Oxford); 2015 Jun; 17(6):477-84. PubMed ID: 25728543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
